These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6411576)

  • 21. Factor VIII procoagulant activity, factor VIII related antigen and von Willebrand factor in newborn cord blood.
    Fukui H; Takase T; Ikari H; Murakami Y; Okubo Y; Nakamura K
    Br J Haematol; 1979 Aug; 42(4):637-46. PubMed ID: 314304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of von Willebrand factor, factor VIII related antigen and factor VIII coagulant response to human growth hormone infusion in type 2 diabetes mellitus.
    Grecu EO; Sheikholislam BM; Abildgaard CF
    Am J Med Sci; 1984; 287(2):3-6. PubMed ID: 6424471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Von Willebrand's disease: combined qualitative and quantitative abnormalities.
    Gralnick HR; Sultan Y; Coller BS
    N Engl J Med; 1977 May; 296(18):1024-30. PubMed ID: 300468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction between factor VIII clotting antigen and phospholipids in genetic variants of hemophilia and von Willebrand's disease.
    Kobayashi I; Lamme S; Nilsson IM
    Thromb Res; 1984 Jul; 35(1):65-75. PubMed ID: 6433504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor VIII/von Willebrand factor binding to von Willebrand's disease platelets.
    Gralnick HR; Williams SB; Shafer BC; Corash L
    Blood; 1982 Aug; 60(2):328-32. PubMed ID: 6807372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Von Willebrand factor multimer patterns in von Willebrand's disease.
    Hoyer LW; Rizza CR; Tuddenham EG; Carta CA; Armitage H; Rotblat F
    Br J Haematol; 1983 Nov; 55(3):493-507. PubMed ID: 6416288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis.
    Drouin J; Lillicrap DP; Izaguirre CA; Sutherland M; Windsor S; Benford K; Hoogendorn H; Giles AR
    Am J Clin Pathol; 1989 Oct; 92(4):471-8. PubMed ID: 2508465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J; Peake I; Bloom A
    Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo dissociation of factor VII (AHF) activity and factor VII-related antigen in von Willebrand's disease.
    Lian EC; Deykin D
    Am J Hematol; 1976; 1(1):71-8. PubMed ID: 1086597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Modification of plasma blood coagulation factor activity by physical stress].
    Lutze G; Buhl H; Häcker R; Socha C; Socha U; Urbahn H
    Z Gesamte Inn Med; 1986 Sep; 41(18):502-5. PubMed ID: 3099480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbohydrate deficiency of the factor VIII/von Willebrand factor Protein in von Willebrand's disease variants.
    Gralnick HR; Coller BS; Sultan Y
    Science; 1976 Apr; 192(4234):56-9. PubMed ID: 1083071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.
    Ludlam CA; Peake IR; Allen N; Davies BL; Furlong RA; Bloom AL
    Br J Haematol; 1980 Jul; 45(3):499-511. PubMed ID: 6775673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrepant increase in factor VIII: C and von Willebrand factor after DDAVP infusion in a patient with variant von Willebrand's disease.
    Casonato A; Sartori MT; Pontara E; Bertomoro A; Dannhäuser D; Girolami
    Blood Coagul Fibrinolysis; 1991 Aug; 2(4):567-73. PubMed ID: 1768767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precipitating antibodies to factor VIII/von Willebrand factor in von Willebrand's disease: effects on replacement therapy.
    Mannucci PM; Ruggeri ZM; Ciavarella N; Kazatchkine MD; Mowbray JF
    Blood; 1981 Jan; 57(1):25-31. PubMed ID: 6778538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A variant of von Willebrand's disease with abnormal expression of factor VIII procoagulant activity.
    Montgomery RR; Hathaway WE; Johnson J; Jacobson L; Muntean W
    Blood; 1982 Jul; 60(1):201-7. PubMed ID: 6805535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of epinephrine infusion in patients with von Willebrand's disease.
    Rickles FR; Hoyer LW; Rick ME; Ahr DJ
    J Clin Invest; 1976 Jun; 57(6):1618-25. PubMed ID: 1084352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.
    Koedam JA; Meijers JC; Sixma JJ; Bouma BN
    J Clin Invest; 1988 Oct; 82(4):1236-43. PubMed ID: 2971673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a His54Gln substitution in von Willebrand factor from a patient with defective binding of factor VIII.
    Rick ME; Krizek DM
    Am J Hematol; 1996 Apr; 51(4):302-6. PubMed ID: 8602631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.